Skip to main content

Advertisement

Log in

Photodynamic Therapy as Alternative Method of Treatment of Metastatic Ovarian Cancer with Many Recurrence: Case Report

  • Published:
BioNanoScience Aims and scope Submit manuscript

Abstract

Photodynamic therapy (PDT) is a minimally invasive therapeutic modality used for the treatment of a variety of cancers and benign diseases. The destruction of unwanted cells and tissues in PDT is achieved by the use of visible or near-infrared radiation to activate a light-absorbing compound (a photosensitizer), which, in the presence of molecular oxygen, leads to the production of singlet oxygen and other reactive oxygen species. Thus, the purpose of the report is to describe the clinical case of the effective use of intraoperative PDT as a method of treatment of a patient with metastatic cancer. Patient A, 59 years old, had ovarian cancer T3N1M0 stage III with peritoneal carcinomatosis. After intraoperative PDT (1.5 year) treatment, the progression of the process was not revealed by PET/CT. The results show that photodynamic therapy is one of the high efficiency methods of palliative treatment and it can be used for metastatic cancer. This technology should be included as a technique to the guidelines for the treatment of malignant tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Siegel, R., Miller, K., & Jemal, A. (2018). Cancer statistics, 2018. CA: a Cancer Journal for Clinicians, 68(1), 7–30. https://doi.org/10.3322/caac.21442.

    Article  Google Scholar 

  2. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R., Torre, L., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians, 68, 394–424. https://doi.org/10.3322/caac.21492.

    Article  Google Scholar 

  3. Carioli, G., Malvezzi, M., Bertuccio, P., Levi, F., Boffetta, P., & Negri, E. (2019). Cancer mortality and predictions for 2018 in selected Australasian countries and Russia. Annals of Oncology, 30(1), 132–142. https://doi.org/10.1093/annonc/mdy489.

    Article  Google Scholar 

  4. Momenimovahed, Z., Tiznobaik, A., Taheri, S., & Salehiniya, H. (2017). Ovarian cancer in the world: epidemiology and risk factors. Int. J. Women's Health, 11, 287–299. https://doi.org/10.2147/IJWH.S197604.

    Article  Google Scholar 

  5. Hofstetter, G., Concin, N., Braicu, I., Chekerov, R., Sehouli, J., Cadron, I., et al. (2013). The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma-analysis of patient data in the prospective OVCAD study. Gynecologic Oncology, 131, 15–20. https://doi.org/10.1016/j.ygyno.2013.07.086.

    Article  Google Scholar 

  6. Akeson, M., Zetterqvist, B., Dahllöf, K., Brännström, M., & Horvath, G. (2008). Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up. Acta Obstetricia et Gynecologica Scandinavica, 87, 1343–1352. https://doi.org/10.1080/00016340802495491.

    Article  Google Scholar 

  7. Poveda, A., & Marth, C. (2017). Platinum or nonplatinum in recurrent ovarian cancer: that is the question. Future Oncology, 13(23s), 11–16. https://doi.org/10.2217/fon-2017-0317.

    Article  Google Scholar 

  8. Casson, A. (2009). Photofrin PDT for early stage esophageal cancer: a new standard of care? Photodiagnosis and Photodynamic Therapy, 6, 155–156. https://doi.org/10.1016/j.pdpdt.2009.09.002.

    Article  Google Scholar 

  9. Ikeda, N., Usuda, J., Kato, H., Ishizumi, T., Ichinose, S., Otani, K., et al. (2011). New aspects of photodynamic therapy for central type early stage lung cancer. Lasers in Surgery and Medicine, 43, 749–754. https://doi.org/10.1002/lsm.21091.

    Article  Google Scholar 

  10. Spinelli, P., Dal Fante, M., & Mancini, A. (1992). Current role of laser and photodynamic therapy in gastrointestinal tumors and analysis of a 10-year experience. Seminars in Surgical Oncology, 8, 204–213. https://doi.org/10.1002/ssu.2980080405.

    Article  Google Scholar 

  11. Hong, E., Choi, D., & Shim, M. (2016). Targeted and effective photodynamic therapy for cancer using functionalized nanomaterials. Acta Pharmaceutica Sinica B, 6(4), 297–307. https://doi.org/10.1016/j.apsb.2016.01.007.

    Article  Google Scholar 

  12. Moghissi, K., Dixon, K., & Gibbins, S. (2015). A surgical view of photodynamic therapy in oncology: a review. Surgery Journal (New York, N.Y.), 1(1), 1–15. https://doi.org/10.1055/s-0035-1565246.

    Article  Google Scholar 

  13. Kessel, D., & Oleinick, N. (2018). Cell death pathways associated with photodynamic therapy: an update. Photochemistry and Photobiology, 94, 213–218. https://doi.org/10.1111/php.12857.

    Article  Google Scholar 

  14. Löning, M., Diddens, H., Küpker, W., Diedrich, K., & Hüttmann, G. (2004). Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5-aminolevulinic acid-induced protoporphyrin IX. Cancer., 100(8), 1650–1656. https://doi.org/10.1002/cncr.20155.

    Article  Google Scholar 

  15. Hendren, S., Hahn, S., & Spitz, F. (2001). Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Annals of Surgical Oncology, 8(1), 65–71. https://doi.org/10.1007/s10434-001-0065-x.

    Article  Google Scholar 

  16. Wakui, M., Yokoyama, Y., Wang, H., Shigeto, T., Futagami, M., & Mizunuma, H. (2010). Efficacy of a methyl ester of 5-aminolevulinic acid in photodynamic therapy for ovarian cancers. Journal of Cancer Research and Clinical Oncology, 136(8), 1143–1150. https://doi.org/10.1007/s00432-010-0761-7.

    Article  Google Scholar 

  17. Nath, S., Saad, M., Pigula, M., Swain, J., & Hasan, T. (2019). Photoimmunotherapy of ovarian cancer: a unique niche in the management of advanced disease. Cancers, 11(12), 1887. https://doi.org/10.3390/cancers11121887.

    Article  Google Scholar 

  18. Kobayashi, H., & Choyke, P. (2019). Near-infrared photoimmunotherapy of cancer. Accounts of Chemical Research, 52(8), 2332–2339. https://doi.org/10.1021/acs.accounts.9b00273.

    Article  Google Scholar 

Download references

Acknowledgments

This study was supported by the Russian Government Program of Competitive Growth of Kazan Federal University.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. I. Bilyalov.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bilyalov, A.I., Shanazarov, N.A. & Zinchenko, S.V. Photodynamic Therapy as Alternative Method of Treatment of Metastatic Ovarian Cancer with Many Recurrence: Case Report. BioNanoSci. 10, 807–810 (2020). https://doi.org/10.1007/s12668-020-00749-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12668-020-00749-7

Keywords

Navigation